Holen Sie sich die Stockscreener-App
3.61
4.18%
0.145
Finanzdaten der Titan Pharmaceuticals Inc De-Aktie (TTNP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.004 | 0.083 | 0.098 |
| Operating Expenses |
30.30%
1.063
|
1.525 | 2.471 | 1.671 | 1.795 |
| Operating Income/Loss |
30.30%
-1.063
|
-1.525 | -2.467 | -1.588 | -1.697 |
| Nonoperating Income/Loss |
107.69%
0.003
|
-0.039 | 1.723 | 0.002 | 0.022 |
| Income/Loss From Continuing Operations Before Tax |
125.30%
-1.06
|
4.189 | -0.744 | -1.586 | -1.675 |
| Income/Loss From Continuing Operations After Tax |
32.23%
-1.06
|
-1.564 | -0.744 | -1.586 | -1.675 |
Net Income/Loss
|
32.23%
-1.06
|
-1.564 | -0.744 | -1.586 | -1.675 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
8.01 | - | - | - |
| Basic Average Shares |
105.98%
0.853
|
-14.26 | 15.02 | 15.02 | - |
| Diluted Average Shares |
105.98%
0.853
|
-14.26 | 15.02 | 15.02 | 15.02 |
| Basic Earnings Per Share |
82.63%
-1.24
|
-7.14 | -0.05 | -0.11 | -0.11 |
| Diluted Earnings Per Share |
82.63%
-1.24
|
-7.14 | -0.05 | -0.11 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.50%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):